[Rifampicin in Klebsiella pneumoniae septicemia].
D000328:Adult; D002228:Carbenicillin / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D006801:Humans; D007711:Klebsiella pneumoniae / Q000302:isolation & purification*; D008297:Male; D009268:Nalidixic Acid / Q000627:therapeutic use; D011511:Proteus / Q000302:isolation & purification; D011512:Proteus Infections / Q000188:drug therapy; D012293:Rifampin / Q000627:therapeutic use*; D018805:Sepsis / Q000188:drug therapy* / Q000382:microbiology; D012853:Sisomicin / Q000627:therapeutic use; D014556:Urine / Q000382:microbiology
D009268:Nalidixic Acid; D002228:Carbenicillin; D012293:Rifampin; D012853:Sisomicin
Rifampicin bei Sepsis durch Klebsiella pneumoniae.